IL6 and chronic myelogenous leukemia, BCR-ABL1 positive: Even more, our recent study described the effective role of CIGB-258 and tocilizumab (IL-6 inhibitor) towards the revival of zebrafish swimming patterns against CML-induced acute paralysis [27,31].